Affordable Access

Activity of bevacizumab (rhuMAB VEGF) in advanced refractory epithelial ovarian cancer.

Authors
  • Monk, Bradley J
  • Choi, David C
  • Pugmire, Gordon
  • Burger, Robert A
Type
Published Article
Journal
Gynecologic oncology
Publication Date
Mar 01, 2005
Volume
96
Issue
3
Pages
902–905
Identifiers
PMID: 15721449
Source
Medline
License
Unknown

Abstract

Bevacizumab has activity in epithelial ovarian carcinoma and larger scale trials are indicated.

Report this publication

Statistics

Seen <100 times